Investment Thesis
BIO KEY INTERNATIONAL is a deteriorating cash-negative business with revenue declining 14.3% YoY and net losses accelerating 66.4% YoY. Despite a strong 76.9% gross margin, severe operating expense drag produces -115% operating margins and -$4.7M operating cash burn, leaving only ~7 months of runway at current burn rates before cash depletion.
Strengths
- 76.9% gross margin indicates strong product pricing power or efficient COGS management
- Zero long-term debt eliminates leverage and bankruptcy risk from creditors
- 1.47x current ratio and 1.35x quick ratio provide adequate short-term liquidity
Risks
- Revenue declining 14.3% YoY signals shrinking market demand or lost customers
- Operating losses of -$6.8M and -115% operating margin indicate unsustainable business model
- Operating cash flow negative at -$4.7M with deteriorating net income (-66.4% YoY) suggests accelerating downward spiral
- Cash runway of ~7 months at current burn rate creates existential liquidity risk
- Zero insider Form 4 filings in last 90 days indicates management lacks confidence to buy shares
- No clear path to profitability given widening losses despite decent gross margins
Key Metrics to Watch
- Operating cash flow trend - any improvement toward positive would be critical turning point
- Revenue stabilization - further decline accelerates cash depletion timeline
- Operating expense reduction rate - must cut costs faster than revenue is falling to reach breakeven
- Cash position and runway remaining - monitor monthly burn rate closely for covenant violations or financing needs
Financial Metrics
Revenue
5.9M
Net Income
-7.2M
EPS (Diluted)
$-0.01
Free Cash Flow
-4.7M
Total Assets
8.3M
Cash
2.7M
Profitability Ratios
Gross Margin
76.9%
Operating Margin
-115.0%
Net Margin
-120.6%
ROE
-140.2%
ROA
-86.2%
FCF Margin
-78.8%
Balance Sheet & Liquidity
Current Ratio
1.47x
Quick Ratio
1.35x
Debt/Equity
0.00x
Debt/Assets
38.5%
Interest Coverage
-5,035.11x
Long-term Debt
0.0
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-06-13T07:13:18.160257 |
Data as of: 2025-12-31 |
Powered by Claude AI